Sight Sciences
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2011-01-01
- Employees
- 214
- Market Cap
- -
- Website
- http://www.sightsciences.com
- Introduction
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)
- Conditions
- Primary Open Angle GlaucomaCataract
- First Posted Date
- 2025-04-29
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT06948773
- Locations
- 🇵🇦
Panama Eye Center, Panama City, Panama
A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma
- Conditions
- Primary Open Angle Glaucoma
- Interventions
- Device: OMNI Surgical System
- First Posted Date
- 2024-05-09
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT06407973
- Locations
- 🇺🇸
North Bay Eye Associates, Petaluma, California, United States
🇺🇸University Eye Specialists, Maryville, Tennessee, United States
A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
- Conditions
- Glaucoma, Open-Angle
- Interventions
- Device: OMNI® Surgical System
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT05044793
- Locations
- 🇺🇸
Grene Vision Group, Wichita, Kansas, United States
🇺🇸Northern Ophthalmics, Jenkintown, Pennsylvania, United States
🇺🇸Oklahoma Eye Surgeons, Oklahoma City, Oklahoma, United States
An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0)
- Conditions
- Glaucoma, Open-Angle
- Interventions
- Device: OMNI® Surgical System
- First Posted Date
- 2021-05-04
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT04872348
- Locations
- 🇺🇸
University Eye Specialists, Maryville, Tennessee, United States
🇺🇸El Paso Eye Surgeons, El Paso, Texas, United States
🇺🇸Virginia Eye Consultants, Norfolk, Virginia, United States
Prospective, Randomized, Masked, Controlled Trial To Evaluate The Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)
- Conditions
- Dry EyeMeibomian Gland Dysfunction
- Interventions
- Device: TearCare System
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 350
- Registration Number
- NCT04795752
- Locations
- 🇺🇸
Harvard Eye Associates, Laguna Hills, California, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
🇺🇸Doctor My Eyes, Scottsdale, Arizona, United States
Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)
- Conditions
- Glaucoma, Open-Angle
- Interventions
- Device: OMNI® Surgical SystemDevice: iStent inject
- First Posted Date
- 2020-12-08
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04658095
- Locations
- 🇪🇸
Universidad Complutense de Madrid, Valencia, Spain
🇪🇸Paseo Isabel la Católica 1-3. Edificio general Hospital Miguel Servet. Planta calle, Zaragoza, Spain
🇩🇪BurgerHospital, Frankfurt, Germany
A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma
- Conditions
- Glaucoma, Open-Angle
- Interventions
- Device: iStent injectDevice: OMNI® Surgical System
- First Posted Date
- 2020-11-05
- Last Posted Date
- 2022-12-01
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT04616573
- Locations
- 🇺🇸
Eye Associates and SurgiCenter of Vineland, Vineland, New Jersey, United States
🇺🇸Eye Center South, Dothan, Alabama, United States
A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma
- Conditions
- Glaucoma, Open-Angle
- Interventions
- Device: OMNI® Surgical System
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT04465630
- Locations
- 🇺🇸
Assil Eye Institute, Santa Monica, California, United States
🇺🇸Utah Eye Centers, Ogden, Utah, United States
🇺🇸Vold Vision, Fayetteville, Arkansas, United States
Study of OMNI System in OAG (GEMINI)
- Conditions
- Open Angle Glaucoma
- Interventions
- Device: Transluminal viscoelastic delivery and trabeculotomy
- First Posted Date
- 2019-03-04
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 209
- Registration Number
- NCT03861169
- Locations
- 🇺🇸
Vold Vision, Fayetteville, Arkansas, United States
🇺🇸Eye Center South, Dothan, Alabama, United States
🇺🇸Eye Physicians and Surgeons, LLP, Iowa City, Iowa, United States
TearCare System to Treat Dry Eye Disease
- Conditions
- Meibomian Gland DysfunctionDry Eye
- Interventions
- Device: LipiFlowDevice: TearCare
- First Posted Date
- 2019-02-28
- Last Posted Date
- 2019-09-18
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 138
- Registration Number
- NCT03857919
- Locations
- 🇺🇸
Center for Excellence in Eye Care, Miami, Florida, United States